Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 777 | 819 | 808 | 824 | 837 |
| TOTAL | $796 | $845 | $832 | $862 | $884 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 0 | 0 | 43 | 49 | 55 |
| TOTAL | $N/A | $N/A | $43 | $49 | $55 |
| Total Assets | $796 | $845 | $875 | $911 | $939 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 62 | 81 | 79 | 65 | 61 |
| TOTAL | $62 | $81 | $79 | $65 | $61 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $62 | $81 | $79 | $65 | $61 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29 | 29 | 29 | 29 | 29 |
| Retained earnings | -3,499 | -3,470 | -3,437 | -3,387 | -3,355 |
| TOTAL | $734 | $764 | $796 | $846 | $878 |
| Total Liabilities And Equity | $796 | $845 | $875 | $911 | $939 |